1. The relationship between betablockade, hyporeninaemic and hypotensive effect of two beta-blocking agents;AMERY, A.; PLAEN, D.E.; F., J.; FAGARD, R.; LUJNEN, P.; REYBROUCK, T.;Postgraduate Medical Journal,1976
2. A new type of cardioselective adrenoceptive blocking drug;BARRETT, A.M.; CARTER, J.; FITZGERALD, J.D.; HULL, R.; COUNT, L.E.; D.;British Journal of Pharmacology,1973
3. Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66.082), a new cardioselective 13-adrenoceptor blocking drug;CONWAY, F.J.; FITZGERALD, J.D.; McAINSH, J.; ROWLANDS, D.J.; SIMPSON, W.J.;British Journal of Clinical Pharmacology,1976
4. Oncedaily dosing with atenolol in patients with mild or moderate hypertension;DOUGLAS-JONES, A.P.; CRUICKSHANK, J.M.;British Medical Journal,1976
5. Raynaud's phenomenon as side effect of beta-blockers in hypertension;MARSHALL, A.J.; ROBERTS, C.J.; BARRITT, D.W.;British Medical Journal,1976